TY - JOUR
T1 - Sleep-disordered breathing and cardiovascular disease in children and adolescents
T2 - A scientific statement from the American heart association
AU - American Heart Association Athero
AU - Hypertension and Obesity in the Young Committee of the Council on Lifelong Congenital Heart Disease
AU - Heart Health in the Young
AU - Baker-Smith, Carissa M.
AU - Isaiah, Amal
AU - Melendres, Maria Cecilia
AU - Mahgerefteh, Joseph
AU - Lasso-Pirot, Anayansi
AU - Mayo, Shawyntee
AU - Gooding, Holly
AU - Zachariah, Justin
N1 - Publisher Copyright:
© 2021 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.
PY - 2021/9/21
Y1 - 2021/9/21
N2 - Obstructive sleep apnea (OSA) is a known risk factor for cardiovascular disease in adults. It is associated with incident systemic hypertension, arrhythmia, stroke, coronary artery disease, and heart failure. OSA is common in children and adolescents, but there has been less focus on OSA as a primary risk factor for cardiovascular disease in children and adolescents. This scientific statement summarizes what is known regarding the impact of sleep-disordered breathing and, in particular, OSA on the cardiovascular health of children and adolescents. This statement highlights what is known regarding the impact of OSA on the risk for hypertension, arrhythmia, abnormal ventricular morphology, impaired ventricular contractility, and elevated right heart pressure among children and adolescents. This scientific statement also summarizes current best practices for the diagnosis and evaluation of cardiovascular disease-related complications of OSA in children and adolescents with sleep apnea and highlights potential future research in the area of sleep-disordered breathing and cardiovascular health during childhood and adolescence.
AB - Obstructive sleep apnea (OSA) is a known risk factor for cardiovascular disease in adults. It is associated with incident systemic hypertension, arrhythmia, stroke, coronary artery disease, and heart failure. OSA is common in children and adolescents, but there has been less focus on OSA as a primary risk factor for cardiovascular disease in children and adolescents. This scientific statement summarizes what is known regarding the impact of sleep-disordered breathing and, in particular, OSA on the cardiovascular health of children and adolescents. This statement highlights what is known regarding the impact of OSA on the risk for hypertension, arrhythmia, abnormal ventricular morphology, impaired ventricular contractility, and elevated right heart pressure among children and adolescents. This scientific statement also summarizes current best practices for the diagnosis and evaluation of cardiovascular disease-related complications of OSA in children and adolescents with sleep apnea and highlights potential future research in the area of sleep-disordered breathing and cardiovascular health during childhood and adolescence.
KW - AHA Scientific Statements
KW - Arrhythmia
KW - Cardiovascular disease
KW - Left ventricular hypertrophy
KW - Obstructive sleep apnea
KW - Pediatric
KW - Sleep-disordered breathing
KW - Systemic hypertension
UR - http://www.scopus.com/inward/record.url?scp=85117425598&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85117425598&partnerID=8YFLogxK
U2 - 10.1161/JAHA.121.022427
DO - 10.1161/JAHA.121.022427
M3 - Article
C2 - 34404224
AN - SCOPUS:85117425598
SN - 2047-9980
VL - 10
JO - Journal of the American Heart Association
JF - Journal of the American Heart Association
IS - 18
M1 - e022427
ER -